The FDA has accepted for review the resubmitted BLA for prademagene zamikeracel for recessive dystrophic epidermolysis bullosa.

The United States contributed to the Epidermolysis Bullo's highest prevalent cases, accounting for ~65% of the 7MM in 2023.

Carol Schober-Flores, BSN, RN, is a Mohs Surgical Nurse and Epidermolysis Bullosa Nurse Specialist, University Hospital, Denver, CO. Topical ointments can be applied directly over the Mepitel ...

Abeona Therapeutics Inc ( (ABEO) ) has released its Q3 earnings. Here is a breakdown of the information Abeona Therapeutics Inc presented to ...

Irish actor Colin Farrell recently finished the Dublin Marathon in 4:06:45, and he ran the last 2.5 miles while pushing his ...

The final 4 kilometers (2.5 miles) of this marathon became a true symbol of life and the most beautiful friendship anyone can ...

However, in recent years he has worked as vice president of Debra UK, helping to raise awareness of epidermolysis bullosa (EB ...

Relief Therapeutics announces positive final results of RLF-TD011 trial in epidermolysis bullosa: Geneva Tuesday, November 12, 2024, 10:00 Hrs [IST] Relief Therapeutics Holding SA ...

FDA accepts BLA resubmission of pz-cel in recessive dystrophic epidermolysis bullosa and sets PDUFA target action date of April 29, 2025Company ...

Award-winning actor and runner Colin Farrell finished the Dublin Marathon in 4:06:45 while pushing his friend in wheelchair ...

The 'Penguin' star and his friend Emma Fogarty, who has the skin condition epidermolysis bullosa (EB), raised over $850,000 ...